89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 158 filers reported holding 89BIO INC in Q2 2023. The put-call ratio across all filers is 2.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $155,033 | +336.1% | 10,041 | +435.2% | 0.01% | +400.0% |
| Q2 2023 | $35,551 | +28340.8% | 1,876 | -77.1% | 0.00% | -75.0% |
| Q1 2023 | $125 | +220.5% | 8,179 | +167.4% | 0.00% | +100.0% |
| Q4 2022 | $39 | -99.9% | 3,059 | -73.3% | 0.00% | +100.0% |
| Q3 2022 | $67,000 | +857.1% | 11,452 | +395.1% | 0.00% | – |
| Q2 2022 | $7,000 | -50.0% | 2,313 | -38.3% | 0.00% | – |
| Q1 2022 | $14,000 | -62.2% | 3,747 | +32.9% | 0.00% | -100.0% |
| Q4 2021 | $37,000 | +362.5% | 2,820 | +577.9% | 0.00% | – |
| Q3 2021 | $8,000 | -94.8% | 416 | -94.9% | 0.00% | -100.0% |
| Q2 2021 | $153,000 | +313.5% | 8,192 | +419.5% | 0.00% | +300.0% |
| Q1 2021 | $37,000 | +15.6% | 1,577 | +21.4% | 0.00% | 0.0% |
| Q4 2020 | $32,000 | -66.7% | 1,299 | -65.4% | 0.00% | 0.0% |
| Q3 2020 | $96,000 | +74.5% | 3,755 | +36.0% | 0.00% | -50.0% |
| Q2 2020 | $55,000 | – | 2,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |